POC Blood Gas and Electrolyte Companies

Top Industry Leaders in the POC Blood Gas and Electrolyte Market

Latest POC Blood Gas and Electrolyte Companies Update

Nov 2023: Listed in Frankfurt Advisors are assisting Siemens Healthineers in researching possibilities for the division. According to them, the evaluation might result in the sale or carve-out of its in-vitro diagnostics division, which tests blood and tissue samples to detect illnesses and disorders. The stock reached its highest level in three months on Friday morning, rising as much as 4.7%. The source stated that although all alternatives are still open, the review might result in the unit being sold. They said discussions are still in their early stages and that no banks have been given mandates. The company's diagnostics business had a 20% decline in revenue in the third quarter due to a decline in test demand. Restructuring is also underway in the diagnostics industry.

May 2023: A long-acting, broad-spectrum cephalosporin antibiotic is called Roche's Rocephin. F. Hoffmann-La Roche Ltd. is credited. Roche, a Swiss healthcare company, has sold its mainland China sales rights to Hasten Biopharmaceutical. With the purchase completed earlier in 2023, there will now be an adjustment period between the two corporations. Hasten also acquired Rocephin's intellectual property, trademarks, and marketing authority. Parenterally administered, rocephin is a long-acting, broad-spectrum cephalosporin antibiotic. It is approved for treating sepsis, meningitis, and infections of the stomach, bones, joints, soft tissues, and skin in adults and children.

List of POC Blood Gas and Electrolyte Key companies in the market